PharmaZen receivers hit back at board’s ‘misleading statement’
The board of the USX-listed company criticised BNZ Bank for appointing receivers to the company.
AiOra is PharmaZen/Waitaki’s branded product range of freeze-dried bovine organs and glands.
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
The receivers of USX-listed nutraceuticals company PharmaZen have had the market operator take down the company’s critical announcement of their appointment, saying their statement was “inaccurate and misleading”.
PharmaZen’s board's statement to the market this morning hit out at at BNZ
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
